Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: A single-centre prospective analysis

European Journal of Cancer Care

Volumn 19, Issue 5, 2010, Pages 676-681

  Heibl, C ^a   Trommet, V ^a   Burgstaller, S ^a   Mayrbaeurl, B ^a   Baldinger, C ^a   Koplmuller R ^a   Kuhr T ^a   Wimmer, L ^a   Thaler, J ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Central venous catheter; Complications; Infection; Port a Cath

Indexed keywords

ARTICLE; CENTRAL VENOUS CATHETERIZATION; DEVICE REMOVAL; HEMATOLOGIC DISEASE; HUMAN; INDWELLING CATHETER; INFECTION; INSTRUMENTATION; NEOPLASM; PROSPECTIVE STUDY; THROMBOSIS;

CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; DEVICE REMOVAL; HEMATOLOGIC DISEASES; HUMANS; NEOPLASMS; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; THROMBOSIS;

EID: 77955729990     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2009.01115.x     Document Type: Article

References (24)

1. Barrios CH, Zuke JE, Blaes B, Hirsch JD, Lyss AP. Evaluation of an implantable venous access system in a general oncology population. Oncology 1992, 49:474-478.
2. Bern MM, Lockich JJ, Wallach SR, Bothe A, Benotti PN, Arkin CF, Greco FA, Hubermann M, Moor C. Very low dose of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Annals of Internal Medicine 1990, 112:423-428.
3. Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nole F, Andreoni B. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Annals of Oncology 1998, 9:767-773.
4. Brincker H, Saeter G. Fifty-five patient years experience with a totally implanted system for intravenous chemotherapy. Cancer 1986, 57:1124-1129.
5. Brothers TE, Von Moll LK, Niederhuber JE, Roberts JA, Walker-Andrews S, Ensminger WD. Experience with subcutaneous infusion ports in three hundred patients. Surgery Gynecology & Obstetrics 1988, 166:295-301.
6. Couban S, Goodyear M, Burnell M, Dolan S, Wasi P, Barnes D, MacLeod D, Burton E, Andreou P, Anderson DR. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. Journal of Clinical Oncology 2005, 23:4063-4069.
7. Groeger JS, Lucas AB, Thaler HT, Friedlander-Klar H, Brown AE, Kiehn TE, Armstrong D. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Annals of Internal Medicine 1993, 119:1168-1174.
8. Harvey WH, Pick TE, Reed K, Solenberger RI. A prospective evaluation of the Port-a-Cath implantable venous access system in chronically ill adults and children. Surgery Gynecology & Obstetrics 1989, 169:495-500.
9. Kellner O, Schmoll HJ. Zentralvenöse Zugänge für die Tumortherapie: Zentralvenöse katheter. Kompendium Internistische Onkologie 2006, 1153-1161. Schmoll HJ, Hoeffken KPossinger K. In, 3rd, edn (eds, pp., Springer, Berlin
10. Kock HJ, Pietsch M, Krause U, Wilke H, Eigler FW. Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World Journal of Surgery 1998, 22:12-16.
11. Kuo YS, Schwartz B, Santiago J, Anderson PS, Fields AL, Goldberg GL. How often should a port-A-cath be flushed? Cancer Investigation 2005, 23:582-585.
12. Laffer U, Durig M, Bloch HR, Zuber M, Stoll HR. Implantable catheter systems. Experience with 205 patients. Deutsche Medizinische Wochenschrift 1989, 114:655-658.
13. Lersch C, Kotowa W, Fung S, Janssen D. Prophylaxis of port system-associated thromboses in advanced oncology patients using heparin flushing. Journal of Cancer Research and Clinical Oncology 2004, 130:235-241.
14. Levine M, Kakkar AK. Catheter-associated thrombosis: thromboprophylaxis or not? Journal of Clinical Oncology 2005, 23:4006-4008.
15. Lokich JJ, Bothe A, Benotti P, Moore C. Complications and management of implanted venous access catheters. Journal of Clinical Oncology 1985, 3:710-717.
16. Masci G, Magagnoli M, Zucali PA, Castagna L, Carnaghi C, Sarina B, Pedicini V, Fallini M, Santoro A. Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy? Journal of Clinical Oncology 2003, 21:736-739.
17. Monreal M, Alastrue A, Rull M, Mira X, Muxart J, Rosell R, Abad A. Upper extremity deep venous thrombosis in cancer patients with venous access devices - prophylaxis with a low molecular weight heparin (Fragmin). Journal of Thrombosis and Haemostasis 1996, 75:251-253.
18. Poorter RL, Lauw FN, Bemelman WA, Bakker PJM, Taat CW, Veenhof CHN. Complications of an implantable venous access device (Port-a-Cath) during intermittent continuous infusion of chemotherapy. European Journal of Cancer 1996, 32:2262-2266.
19. Schwarz RE, Groeger JS, Coit DG. Subcutaneously implanted central venous access devices in cancer patients. A prospective analysis. Cancer 1997, 79:1635-1640.
20. Stein M, Wagner RH. Complications of central venous access devices: outcome analysis of 2359 implantations. Deutsche Medizinische Wochenschrift 2005, 130:1129-1132.
21. Torramade JR, Cienfuegos JA, Hernandez JL, Pardo F, Benito C, Gonzalez J, Balen E, de Villa V. The complications of central venous access systems: a study of 218 patients. European Journal of Surgery 1993, 159:323-327.
22. Vardy J, Engelhardt K, Cox K, Jacquet J, McDade A, Boyer M, Beale P, Stockler M, Longeragan R, Dennien B, Waugh R, Clarke SJ. Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature. British Journal of Cancer 2004, 91:1045-1049.
23. Verso M, Agnelli G, Bertoglio S, Di Somma FC, Paoletti F, Ageno W, Bazzan M, Parise P, Quintavalla R, Naglieri E, Santoro A, Imberti D, Soraru M, Mosca S. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. Journal of Clinical Oncology 2005, 23:4057-4062.
24. Wolosker N, Yazbek G, Nishinari K, Malavolta LC, Munia MA, Langer M, Zerati AE. Totally implantable venous catheters for chemotherapy: experience in 500 patients. Sao Paolo Medical Journal 2004, 122:147-151.